EP3256109
PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.2.2016EP published:
14.7.2021EP application number:
16706551.5
EP translation filed:
5.8.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
8.2.2036Expiry date:
8.2.2027Next due date:
28.2.2027
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE
Timeline
Today
9.2.2016EP application
14.7.2021EP Publication
5.8.2021Translation submitted
15.9.2021Registration published
8.2.2027Expires
Owner
Name:
Astex Therapeutics LimitedAddress:
436 Cambridge Science Park Milton Road, Cambridge Cambridgeshire CB4 0QA, GB
Inventor
Name:
BROGGINI, Diego Fernando DomenicoAddress:
CH-8200 Schaffhausen, CH
Priority
Number:
15154554Date:
10.2.2015Country:
EP
Number:
15188982Date:
8.10.2015Country:
EP
Classification
Categories:
A61K 9/20, A61K 9/48, A61K 47/18, C07D 403/04, A61K 31/498, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.2.2022
Expires: 8.2.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.1.2023
Expires: 8.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.2.2024
Expires: 8.2.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.1.2025
Expires: 8.2.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.2.2026
Expires: 8.2.2027
Payer: Árnason Faktor ehf.